Maze Therapeutics

OverviewSuggest Edit

Maze Therapeutics is translating novel genetic insights into lifesaving medicines, through an approach that integrates human genetics and functional genomics. The Company is focused on building a platform to discover and drug genetic modifiers, genes that can negate the harmful effects of other genes.

TypePrivate
Founded2018
HQRedwood City, CA, US
Websitemazetx.com

Recent NewsAll News

Latest Updates

Employees (est.) (Jan 2021)89(+8%)
Cybersecurity ratingBMore

Key People/Management at Maze Therapeutics

Charles Homcy

Charles Homcy

Chairman of the Board
Tim Behrens

Tim Behrens

Senior Vice President, Human Genetics
Brendan Bulik-Sullivan

Brendan Bulik-Sullivan

Director
Matt Brauer

Matt Brauer

Vice President, Data Science
Tara Nickerson

Tara Nickerson

Chief Business Officer
Jonathan Lim

Jonathan Lim

Director
Show more

Maze Therapeutics Office Locations

Maze Therapeutics has offices in Redwood City and South San Francisco
Redwood City, CA, US (HQ)
123 Saginaw Dr
South San Francisco, CA, US
131 Oyster Point Blvd STE 200
Show all (2)

Maze Therapeutics Financials and Metrics

Summary Metrics

Founding Date

2018

Maze Therapeutics total Funding

$191 m

Time since last funding

a year ago

Maze Therapeutics investors

Show all financial metrics

Maze Therapeutics Cybersecurity Score

Cybersecurity ratingPremium dataset

B

87/100

SecurityScorecard logo

Maze Therapeutics Online and Social Media Presence

Embed Graph

Maze Therapeutics News and Updates

City Hill Ventures funds Maze Therapeutics

Maze Therapeutics, a company focused on translating genetic insights into new medicines, has secured funding from City Hill Ventures. No financial terms were disclosed. In addition to the funding, Dr. Jonathan Lim, founder and managing partner at City Hill, has joined the Maze board of directors.

Maze Therapeutics Blogs

Maze Therapeutics and Alloy Therapeutics Form Broadwing Bio to Develop Antibody Therapies for Genetically Validated Targets in Ophthalmic Diseases

SOUTH SAN FRANCISCO, CALIF., and LEXINGTON, MASS., Dec. 7, 2020 – Maze Therapeutics, a company focused on translating genetic insights into new medicines, and Alloy Therapeutics, a company developing platforms and services to enable drug discovery, today announced the formation...

Maze Therapeutics Expands Experienced Management Team with Appointment of Sarah Noonberg, M.D., Ph.D., as Chief Medical Officer

South San Francisco, October 6, 2020 – Maze Therapeutics, a company focused on translating genetic insights into new medicines, today announced that Sarah Noonberg, M.D., Ph.D., has been appointed as the company’s chief medical officer. Dr. Noonberg brings significant industry...

Maze Therapeutics Appoints City Hill Founder, Jonathan Lim, M.D., to its Board of Directors

South San Francisco, October 23, 2019 – Maze Therapeutics, a company focused on translating genetic insights into new medicines, today announced that Jonathan Lim, M.D., founder and managing partner at City Hill Ventures, has joined the company’s board of directors....

FierceBiotech names Maze Therapeutics as one of its “Fierce 15” Biotech Companies of 2019

South San Francisco, CA – September 23, 2019 – Maze Therapeutics, a company focused on translating genetic insights into new medicines, today announced that it has been named by FierceBiotech as one of 2019’s Fierce 15 biotechnology companies, designating it...

Maze Therapeutics Appoints Drug Development Expert Richard Scheller, Ph.D., to its Board of Directors

SAN FRANCISCO, July 9, 2019 – Maze Therapeutics, a company focused on translating genetic insights into new medicines, today announced that Richard Scheller, Ph.D. has joined the company’s board of directors. We are thrilled to welcome Richard to our board...

Maze Therapeutics Appoints Jason Coloma as Chief Executive Officer and Expands Leadership Team

SAN FRANCISCO, June 18, 2019 – Maze Therapeutics, a company focused on translating genetic insights into new medicines, today announced that Jason Coloma, Ph.D., Maze’s current chief operating officer, has been appointed as chief executive officer. He succeeds interim CEO,...

Maze Therapeutics Frequently Asked Questions

  • When was Maze Therapeutics founded?

    Maze Therapeutics was founded in 2018.

  • Who are Maze Therapeutics key executives?

    Maze Therapeutics's key executives are Charles Homcy, Tim Behrens and Brendan Bulik-Sullivan.

  • How many employees does Maze Therapeutics have?

    Maze Therapeutics has 89 employees.

  • Who are Maze Therapeutics competitors?

    Competitors of Maze Therapeutics include GenVec, Synchronicity Pharma and GeneQuine Biotherapeutics.

  • Where is Maze Therapeutics headquarters?

    Maze Therapeutics headquarters is located at 123 Saginaw Dr, Redwood City.

  • Where are Maze Therapeutics offices?

    Maze Therapeutics has offices in Redwood City and South San Francisco.

  • How many offices does Maze Therapeutics have?

    Maze Therapeutics has 2 offices.